The role of neuroimaging in geriatric psychiatry

Current Opinion in Psychiatry

Volumn 15, Issue 4, 2002, Pages 427-432

  Townsend, Brent A ^a   Petrella, Jeffrey R ^a   Doraiswamy, P Murali ^a  

^a Box 3018DUMC ^*  (United States)

Author keywords

Alzheimer's disease; Diagnosis; Drug development; Geriatric depression; Mild cognitive impairment; Treatment outcomes; Vascular depression

Indexed keywords

AGED; ALZHEIMER DISEASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRAIN ATROPHY; BRAIN MAPPING; BRAIN RADIOGRAPHY; BRAIN REGION; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE COURSE; ENTORHINAL CORTEX; GERONTOPSYCHIATRY; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPECTROSCOPY; STROKE; WHITE MATTER;

EID: 0036302039     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200207000-00014     Document Type: Review

References (29)

1. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer Disease
2. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and AD
3. Hippocampal volume discriminates between normal cognition, questionable and mild dementia in the elderly
4. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images
5. Patterns of brain activation in people at risk for Alzheimer's disease
6. Specificity of brain activation patterns in people at genetic risk for Alzheimer Disease
7. Prefrontal activation patterns in subjects at risk for Alzheimer disease
8. Evaluating the function of hippocampal subregions with high resolution MRI in Alzheimer's disease and aging
9. Dissociation of regional activation in mild AD during visual encoding
10. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease
11. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET)
12. Positron emission tomography in evaluation of dementia
13. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET
14. The psychotic phenomenon in probable Alzheimer's disease: A positron emission tomography study
15. Alteration of rCBf in Alzheimer's disease patients with delusions of theft
16. Brain magnetic resonance spectroscopy: Role in assessing outcomes in Alzheimer's disease
17. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease
18. Quantification of tissue damage in Alzheimer's disease using diffusion tensor and magnetization transfer MRI
19. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: A clinical-pathological study
20. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD
21. Dementia with Lewy bodies studied with Positron Emission Tomography
22. Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions
23. Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: Preliminary findings
24. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression
25. Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study
26. Magnetic resonance imaging correlates of depression after ischemic stroke
27. Hippocampal volume and incident dementia in geriatric depression
28. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression
29. The relationship of MRI subcortical hyperintensities to treatment response in a trial of Sertraline in geriatric depressed outpatients